As multi-ethnic, longitudinal cohorts expand, these composite biomarker panels are expected to define individual risk trajectories, differentiate PD subtypes, and identify windows of therapeutic opportunity before irreversible neurodegeneration sets in

GLP-1 medication users - taking Ozempic, Wegovy, Mounjaro, or similar drugs Diabetes patients - managing type 2 diabetes with comprehensive monitoring needs Weight management participants - enrolled in medically supervised programs Prediabetes individuals - monitoring metabolic health before progression Family history concerns - those with diabetes, heart disease, or metabolic disorders Symptom monitoring - experiencing fatigue, weight changes, or vision issues How It Works Just 3 Steps Order online - no doctor's visit or prescription required for testing Visit any lab location - get blood drawn at 4,000+ nationwide facilities Access secure results - receive comprehensive report within 1-2 business days FAQ What medications require GLP-1 monitoring
Prophylactic antibiotic usage for Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature
Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage